Long Lasting Effect Of New Botulinum Toxin Formulations

Patent No. EP3079714 (titled "Long Lasting Effect Of New Botulinum Toxin Formulations") was filed by Medy TOX on Dec 12, 2014. The application was issued on Nov 25, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GALDERMA HOLDINGAug 24, 2021PLASSERAUD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3079714

MEDY TOX
Application Number
EP14815207A
Filing Date
Dec 12, 2014
Status
Revoked
Nov 25, 2022
Publication Date
Nov 25, 2020